Abstract
Sjögren syndrome (SS) is a multisystem autoimmune disease, primarily targeting salivary and lacrimal glands; skin, nasal and vaginal dryness, along with musculoskeletal pain and fatigue are the most commonly reported symptoms. Hearing loss is hypothesized to be frequent as well. The purpose of this systematic review was to estimate the prevalence of Hearing loss and its different subtypes in patients with Sjögren syndrome. PRISMA guidelines were followed to ensure highest quality for our systematic review. A random effects model meta-analysis and meta-regression was conducted using I2 as heterogeneity indicator. Eleven observational studies were included in this systematic review. Ten of them were cross-sectional, while one study was case–control. Studies were assessed for risk of bias: all were rated to a moderate level, except for two rated to a low level. Pooled prevalence of any type of hearing loss was 52.2%. After excluding studies rated to moderate bias, the pooled prevalence of hearing loss was 36.7%. We also conducted a subgroup analysis depending on type of hearing loss. Pooled prevalence of sensorineural hearing loss was 42.6%., while pooled prevalence of conductive hearing loss and mixed hearing loss were 5% and 2.3%, respectively. Meta-regression was conducted in an effort to identify possible variables capable to explain high heterogeneity between studies. Sample size and year of study were separately found to account for a portion of heterogeneity between studies of sensorineural hearing loss. Year of study was also found to account for a portion of heterogeneity between studies of conductive hearing loss. In conclusion, sensorineural hearing loss, is highly prevalent in patients with Sjögren syndrome. On this basis, early screening and follow-up of patients with Sjögren syndrome by pure tone audiometry is important.
Similar content being viewed by others
References
Qin B, Wang J, Yang Z et al (2015) Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 74:1983–1989
Mavragani CP, Schini M et al (2012) Brief report: adrenal autoimmunity in primary Sjögren’s syndrome. Arthritis Rheum 64:4066–4071. https://doi.org/10.1002/art.34679
Teos LY, Alevizos I (2017) Genetics of Sjögren’s syndrome. Clin Immunol 182:41–47. https://doi.org/10.1016/j.clim.2017.04.018
Liu Z, Chu A (2021) Sjögren’s syndrome and viral infections. Rheumatol Ther 8:1051–1059. https://doi.org/10.1007/s40744-021-00334-8
Teruel M, Barturen G, Martínez-Bueno M et al (2021) Integrative epigenomics in Sjögren’s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature. Sci Rep 11:23292. https://doi.org/10.1038/s41598-021-01324-0
Nocturne G, Mariette X (2013) Advances in understanding the pathogenesis of primary Sjögren’s syndrome. Nat Rev Rheumatol 9:544–556
Brito-Zerón P, Baldini C, Bootsma H et al (2016) Sjögren syndrome. Nat Rev Dis Prim 2:1–20. https://doi.org/10.1038/nrdp.2016.47
Sebastian A, Szachowicz A, Wiland P (2019) Classification criteria for secondary Sjögren’s syndrome. Current state of knowledge. Reumatologia 57:277–280
van Nimwegen JF, van Ginkel MS et al (2018) Validation of the ACR-EULAR criteria for primary Sjögren’s syndrome in a Dutch prospective diagnostic cohort. Rheumatology (Oxford) 57(5):818–825. https://doi.org/10.1093/rheumatology/kex495
Gündüz B, Yildirim N, Güven SC et al (2019) Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome. Turk J Med Sci 49:1647–1654. https://doi.org/10.3906/sag-1901-128
Hatzopoulos S, Amoroso C, Aimoni C et al (2002) Hearing loss evaluation of Sjogren’s syndrome using distortion product otoacoustic emissions. Acta Otolaryngol 122:20–25. https://doi.org/10.1080/00016480260094929
Seeliger T, Bönig L, Witte T et al (2020) Hearing dysfunction in patients with Neuro-Sjögren: a cross-sectional study. Ann Transl Med 8:1069
Thanooja CV, Augustine AM, Lepcha A et al (2018) Audiological profile in primary Sjögren’s syndrome in a tertiary care setting and its clinical implications. Indian J Otolaryngol Head Neck Surg 70:59–65. https://doi.org/10.1007/s12070-015-0956-y
Gk T, Pv V, Pelechas E et al (2019) Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study. Eur Arch Otorhinolaryngol 276:2419–2426
Dalton DS, Cruickshanks KJ, Klein BEK et al (2003) The impact of hearing loss on quality of life in older adults. Gerontologist 43:661–668. https://doi.org/10.1093/geront/43.5.661
Liu CM, Lee CTC (2019) Association of hearing loss with dementia. JAMA Netw Open 2:e198112. https://doi.org/10.1001/jamanetworkopen.2019.8112
Michels TC, Duffy MT, Rogers DJ (2019) Hearing loss in adults: differential diagnosis and treatment. Am Fam Physician 100(2):98–108
Shamseer L, Moher D, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. https://doi.org/10.1136/bmj.g7647
Sterne JA, Hernán MA, Reeves BC et al (2016) ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ. https://doi.org/10.1136/bmj.i4919
Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
Sterne JAC, Sutton AJ, Ioannidis JPA et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. https://doi.org/10.1136/bmj.d4002
Doig JA, Whaley K, Dick WC et al (1971) Otolaryngological aspects of Sjögren’s syndrome. Br Med J 4:460–463
Galarza-Delgado DA, Villegas Gonzalez MJ, Riega Torres J et al (2018) Early hearing loss detection in rheumatoid arthritis and primary Sjögren syndrome using extended high frequency audiometry. Clin Rheumatol 37:367–373. https://doi.org/10.1007/S10067-017-3959-0
Gusmão Fernandesa FL, Guimarãesa AC, Scaramussaa LS et al (2014) Otorhinolaryngological findings in a group of patients with rheumatic diseases. Rev Bras Reumatol 54:172–178
Trott MS, Hughes GB, Calabrese LH et al (1996) Hearing and Sjögren’s syndrome. Ear Nose Throat J 75:666–6668
Tsirves GK, Voulgari PV, Pelechas E et al (2019) Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study. Eur Arch Otorhinolaryngol 276:2419–2426. https://doi.org/10.1007/s00405-019-05487-5
Tumiati B, Casoli P, Parmeggiani A (1997) Hearing loss in the Sjögren syndrome. Ann Intern Med 126:450–453
Ziavra N, Politi EN, Kastanioudakis I et al (2000) Hearing loss in Sjögren’s syndrome patients. A comparative study. Clin Exp Rheumatol 18:725–728
Haile LM, Kamenov K, Briant PS et al (2021) Hearing loss prevalence and years lived with disability, 1990–2019: findings from the global burden of disease study 2019. Lancet 397:996–1009. https://doi.org/10.1016/S0140-6736(21)00516-X/ATTACHMENT/A552CF62-9122-4B03-B1AF-AFCE71BE7E9E/MMC1.PDF
Goman AM, Lin FR (2016) Prevalence of hearing loss by severity in the United States. Am J Public Health 106:1820–1822. https://doi.org/10.2105/AJPH.2016.303299
Emamifar A, Bjoerndal K, Hansen IM (2016) Is hearing impairment associated with rheumatoid arthritis? A review. Open Rheumatol J. https://doi.org/10.2174/1874312901610010026
Ahmadzadeh A, Daraei M, Jalessi M et al (2017) Hearing status in patients with rheumatoid arthritis. J Laryngol Otol 131(10):895–899. https://doi.org/10.1017/S0022215117001670
Jeong J, Lim H, Lee K et al (2019) High risk of sudden sensorineural hearing loss in several autoimmune diseases according to a population-based national sample cohort study. Audiol Neurotol 24:224–230. https://doi.org/10.1159/000502677
Tanaka EA, Barros H, Polanski JF et al (2019) AB0507 hearing loss in systemic lupus erythematosus. Ann Rheum Dis 78:1716–1717. https://doi.org/10.1136/ANNRHEUMDIS-2019-EULAR.5998
Abbasi M, Yazdi Z, Kazemifar AM, Bakhsh ZZ (2013) Hearing loss in patients with systemic lupus erythematosus. Glob J Health Sci 5:102–106
Talal N, Moutsopoulos HM, Kassan SS (eds) (1987) Sjögren’s syndrome. Springer Berlin Heidelberg, Heidelberg
Fauchais AL, Lambert M, Launay D et al (2004) Antiphospholipid antibodies in primary Sjögren’s syndrome: prevalence and clinical significance in a series of 74 patients. Lupus 13:245–248. https://doi.org/10.1191/0961203304lu1006oa
Compadretti GC, Brandolini C, Ignazio T (2005) Sudden sensorineural hearing loss in lupus erythematosus associated with antiphospholipid syndrome: case report and review. Ann Otol Rhinol Laryngol 114:214–218. https://doi.org/10.1177/000348940511400308
Teixeira F, Moreira I, Silva AM et al (2013) Neurological involvement in primary Sjögren syndrome. Acta Reumatol Port 38:29–36
Delalande S, de Seze J, Fauchais A-L, Hachulla E et al (2004) Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 83:280–291. https://doi.org/10.1097/01.md.0000141099.53742.16
Jourde-Chiche N, Mancini J, Dagher N et al (2012) Antimalarial ototoxicity: an underdiagnosed complication? A study of spontaneous reports to the French pharmacovigilance network. Ann Rheum Dis 71:1586–1587
Johansson MSK, Arlinger SD (2003) Prevalence of hearing impairment in a population in Sweden. Int Audiol 42:18–28. https://doi.org/10.3109/14992020309056081
Rodríguez-Valiente A, Álvarez-Montero Ó, Górriz-Gil C, García-Berrocal JR (2020) Prevalence of presbycusis in an otologically normal population. Acta Otorrinolaringologica 71:175–180. https://doi.org/10.1016/j.otoeng.2019.05.003
Nezos A, Mavragani CP (2015) Contribution of genetic factors to Sjögren’s syndrome and Sjögren’s syndrome related lymphomagenesis. J Immunol Res 2015:754825. https://doi.org/10.1155/2015/754825
Psillas G, Binos P, Dimas GG, Daniilidis M, Constantinidis J (2021) Human leukocyte antigen (HLA) influence on prognosis of autoimmune hearing loss. Audiol Res 11:31–37. https://doi.org/10.3390/audiolres11010004
Papadimitraki ED, Kyrmizakis DE, Kritikos I, Boumpas DT (2004) Ear-nose-throat manifestations of autoimmune rheumatic diseases. Clin Exp Rheumatol 22:485–494
Acknowledgements
We do not have any financial relationship to this article.
Funding
We did not receive any funding to conduct this study.
Author information
Authors and Affiliations
Contributions
PV and CN conceptualized, proposed and designed the study. PV and PS searched the literature, screened and selected the eligible studies. SP and PS assessed the quality of the studies included. PV, ZP and SP analyzed the data and carried out the statistical analyses. PV and NC contributed in drafting the manuscript, and all other authors reviewed it critically. All authors take full responsibility for the integrity and accuracy of all aspects of the work.
Corresponding author
Ethics declarations
Conflict of interest
We do not have any conflict of interest to declare.
Consent for publication
All authors agreed to publish in Rheumatology International Journal.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Paraschou, V., Partalidou, S., Siolos, P. et al. Prevalence of hearing loss in patients with Sjögren syndrome: a systematic review and meta-analysis. Rheumatol Int 43, 233–244 (2023). https://doi.org/10.1007/s00296-022-05235-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-022-05235-9